Yegnasubramanian et al. found that although the CT-X antigens undergo DNA hypomethylation and overexpression in primary prostate cancers, these changes were more pronounced in metastatic disease when many CT-X antigens were highly upregulated coincident with poorer prognosis [30]. The gene discussed is CYP27A1; the disease is prostate cancer.